HMGA2 and nasopharyngeal carcinoma: (56) found that high expression of HMGA2 and N stage were independent prognostic factors for nasopharyngeal carcinoma, indicating that high expression of HMGA2 and N stage were associated with poor prognosis in patients with nasopharyngeal carcinoma, suggesting that HMGA2 can be used as an effective prognostic biomarker for nasopharyngeal carcinoma.